| Guardion Health Sciences is a health sciences company that has developed medical foods and medical devices in the ocular health space and that is developing nutraceuticals. Co. formulates and distributes Lumega-Z®, which is designed to replenish and restore the macular protective pigment. Co.'s medical food product, GlaucoCetin is designed to support and protect the mitochondrial function of optic nerve cells and improve blood flow in the ophthalmic artery in patients with glaucoma. Co. invented a proprietary technology, embodied in its medical device, the MapcatSF®, that accurately measures the macular pigment optical density. We show 11 historical shares outstanding datapoints in our GHSI shares outstanding history coverage, used to compute GHSI market cap on those dates.|
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing GHSI market cap history over the course of time is important for investors
interested in comparing GHSI's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of GHSI versus a peer is one thing; comparing
GHSI market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like GHSI can fluctuate over the course of history.
With this page we aim to empower investors researching GHSI by allowing them to research the GHSI market cap history.